Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001722024-19-000017
Filing Date
2019-07-05
Accepted
2019-07-05 17:13:00
Documents
1
Period of Report
2019-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156236116502296.html 4  
1 FORM 4 wf-form4_156236116502296.xml 4 6927
  Complete submission text file 0001722024-19-000017.txt   8514
Mailing Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101
Business Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38958 | Film No.: 19944037

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations